medigraphic.com

2011, Number 1

<< Back Next >>

Anales de Radiología México 2011; 10 (1)

Nephropathy induced by iodinated endovenous contrast media

Osorio VM

Language: Spanish
References: 31
Page: 21-26
PDF size: 187.36 Kb.


ABSTRACT

The use of intravenous contrast media in radiological studies have a great importance. It´s the pillar that´s support some methods such as computed axial tomography (CAT) multi-slice. The quality of the studies obtained with the new generation of these techniques and the different applications in many areas of medicine, have made from CAT one of the most used image methods in hospital practice; accordingly, there is a greater number of patients carried out to studies with iodinated contrast media. This is why it has also increased the possibility that appear complications arising from the toxicity of these contrast media. Despite the high frequency with the contrast media are used, information of medical and paramedical staff in connection with the generalities, side effects, and the related adverse effects is not enough. Many studies have shown that the incidence of complications (especially kidney damage) remains frequent. The induced nephropathy (by iodinated contrast media) is the third cause of acute renal failure in hospitalized patients. It is necessary the recognition of this complication to reduce unjustified exposure of patients to CAT studies requiring intravenous contrast media.


REFERENCES

  1. Yoshinori I, Takahisa Y, Toshiaki S, Ryozo O. Clinical and experimental evidence forn prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci 2005;97:473-488.

  2. Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media. Radiology 1990;175:621-628.

  3. Kanzaki T, Sakagami H. Late phase allergic reaction to a CT contrast médium (iotrolan). J Dermatol 1991;18: 528-531.

  4. Spencer CM, GOA KL. Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium. Drugs 1996;52:899-927.

  5. Solomon R, Biguori C. Selection of contrast media. Kidney Int 2006;69: 539-545.

  6. Solomon R; Contrast-medium-induced acute renal failure. Kidney Int 1998; 53: 230-242.

  7. Brendan B, Parfrey P. Preventing Nephropathy Induced by Contrast Medium. N Engl J Med 2006;354:379-386.

  8. Barret BJ, Carlisle EJ. Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171-178.

  9. Solomon R. The role of osmolality in the incidence of contras-induced nephropathy: A systematic review of angiographic contras media in high risk patients. Kidney International 2005;68:2256-2263.

  10. Morcos SK, Thomsen HS. European Society of Urogenital Radiology guidelines of administering contrast media. Abdom Imaging 2003;28:187-190.

  11. Nash K, Hafeez A, Hou S: Hospitalacquired renal insufficiency. Am J Kidney Dis 2002;39:930- 936.

  12. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;63:243-248.

  13. Itah Y, Yano T, Oishi R. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci 2005;97:473-488.

  14. Liss P, Nygren A, Erikson U, Ulfendahl HR. Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 1998;53:698-702.

  15. Drager LF, Andrade L, Barros de Toledo JF, et al. Renal effects of N- Acetylcystein in patients at risk for contrast nephropathy: decrease in oxidant stress- mediated tubular injury. Nephrol Dial Transplant 2004;19:1803-1807.

  16. Yano T, Itoh Y, Sendo T, Kubota T, Oishi R. Cyclic AMP reverses radiocontrast Mediainduced apoptosis in LLC-PKI cells by activating A kinase/ PI-3 kinase. Kidney Int 2003;64:2052- 2063.

  17. Zhang G, Gurtu V, Kain SR, Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 1997;23:525-531.

  18. Gainza F, Liaño García F. Guías de Actuación en el Fracaso Renal Aguda. Sociedad Española de Nefrología 2007:49-57.

  19. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risk for renal dysfunction with cardiac angiography. Ann Intern Med 1986;104:510-504.

  20. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal Insufficiency after cardiac catheterization in patients 70 years of age and older. Arch Intern Med 1990;150:1237-1242.

  21. Gussenhoven MJ, Ravensbergen J, Van Bockel JH, Feuth JD, Aarts JC. Renal dysfunction after angiography; A risk factor analysis in patients with peripheral vascular disease. J Cardiovasc Surg (Torino) 1991;32:81-86.

  22. Curhan G, et al. Prevention of contrast nephropathy. JAMA 2003:289:606-608.

  23. Goldenberg I. Matctzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. J Am Coll Cardiol 2005;172(ll):1461-71.

  24. Gomes V, Caramori P, et al. Nacetylcyteine does not prevent contrast induced nephropathy after cardiac catheterization with an ionic low osmolality contrast medium: a ulticentre clinical trial. Heart 2005;91:774-778.

  25. Briguori C, Colombo A. Standard vs double dose of Nacetylcysteine lo prevent contrast agent associated nephrotoxicity. European Heart Journal 2004;25:206-211.

  26. Curhan G et al. Prevention of contrast nephropathy. JAMA 2003:289:606-608.

  27. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropaty: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Inter Med 2002;162:329-336.

  28. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, et al. Prevention of contrast-induced nephropaty with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291:2328-2334.

  29. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003;93:C29-34.

  30. Bader BD, Berger ED, Heede MB, Silberbaur I, Duda S, Risler T, et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?. Clin Nephrol 2004;62:17.

  31. Carlo Briguori, Antonio Colombo, Flavio Airoldi, et al. Neprotoxicity of lowosmolality versus iso-osmolality contrast agents: Impact of N-acetylcysteine. Kidney international 2005;68:2250-2255.




2020     |     www.medigraphic.com